Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Mattr Reports Voting Results from Annual Meeting
-
McFarlane Intersects 109.6 metres at 0.69 g/t Gold,
-
RenX Advances Microtec Commercialization with Customer Sample Run in Germany
-
Vertero Advances into Phase 1b Study with VT-5006 for the Treatment of Parkinson’s Disease
-
New 30-Year U.S. National Entrepreneurship Research by Ewing Marion Kauffman Foundation Indicates Rise in New Businesses Since Covid-Era Drop; Identifies Opportunities to Boost Economic Growth
-
Terra Clean Energy Corp. Reports Strong Initial Results from the Airborne Radiometric & Photogrammetric Surveys at Prospector Freedom Uranium Project, Utah; Summer Exploration Program Underway
-
Creative Realities to Participate in Upcoming Craig-Hallum Conference
-
Compass Lexecon Expands Antitrust Expertise With Addition of Two Affiliates
-
The National Association of Special Education Teachers (NASET) Announces Inaugural Trusted Special Education Service Providers Listing
-
Global Indemnity Group, LLC Announces Appointment of Michele Colucci to the Board of Directors
-
Plus Therapeutics Partners with Ephemeral Technologies to Deploy AI Execution Platform for CNS Oncology
-
Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy
-
Asante Provides Financial and Operating Results for the Quarter Ended March 31, 2026
-
SiTime Corporation Announces Proposed Convertible Senior Notes Offering
-
The Most Promising Startups in Web3 Are Pitching at the Louvre in Front of a World-Class Jury
-
Boeing and Gilat Achieve Key In-Cabin Offerability Milestone for Sidewinder Line-fit Multi‑Orbit Solution
-
CRB Horizons Report Reveals Food and Beverage Manufacturers Confront Aging Facilities, Labor Shortages, and Regulatory Pressure Amid Rising Safety Risks
-
Zenas BioPharma Announces Upcoming Presentation of Results from Phase 3 INDIGO Registrational Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD) at EULAR 2026 Congress
-
Antalpha Reports First Quarter 2026 Results
-
Vanqua Bio to Present Positive Biomarker Data from Ongoing Phase 1b Study at Upcoming Medical Conferences
-
Sylogist Appoints Joel Leetzow as New CEO
-
Orezone Reports First Set of Drill Results from Casa Berardi Mine Including 16.10g/t Au over 6.7m and 6.47g/t Au over 21.5m
-
Habitat for Humanity Canada elects National Board of Directors at its annual general meeting
-
Coppernico Channel Samples Intersect 70.1 m of 0.92% Copper and 0.25 g/t Gold at Nioc
-
EyePoint Announces Participation at Upcoming Investor Conferences
-
Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
-
Match2 Joins Phenom Marketplace, Bringing the First Universal Candidate Profile and Connected Talent Network to Phenom-Powered Career Sites
-
Asante Gold Corporation Announces Appointment of Acting Chief Executive Officer
-
In Quebec, Vema Hydrogen and CHARBONE Build Hydrogen Supply Chain to Meet Wellhead-to-Industrial Gas Demand and Reduce Transport Costs
-
Orion Announces Preliminary FY26 Revenue of $86M and Approximately $2M Adjusted EBITDA; Reiterates Expectations for Increased Growth and Profitability in FY 2027
-
NexGold Reports Additional Broad, High-Grade Gold, Drill Intercepts at Goldlund, Supporting Mineral Resource Continuity and Expansion Potential
-
Ambow Education Holding Ltd. (NYSE American: AMBO) Launches HybriU Collaboration Board, Bringing One-Scan Real-Time Collaboration to Meetings, Classrooms, Workshops, and Live Events
-
Medicenna Announces the Finalization of the Terms of its Public Offering of Securities
-
XORTX Announces Closing of US$5 Million Public Offering
-
Reminder: Garrett Motion to Hold Technology and Investor Day on Wednesday May 20, 2026
-
What’s the Next Big Thing in HR Tech? Find Out at Pitchfest 2026
-
Want to be a real Insider this summer? President’s Choice unveils its annual PC® Summer Insiders Report™, featuring bold taste discoveries and endless summer inspiration you won’t want to miss
-
Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis
-
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
-
Osisko Development Appoints Vice President, Sustainable Development
-
Troilus Expands High-Grade West Rim Discovery with 2.92 g/t AuEQ Over 19 m Outside Current Resource and Within 200 Metres of Reserve Pit
-
Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
-
Mantel and Wood Announce MOU to Scale High-Temperature Carbon Capture
-
Tecnoglass Announces Upcoming Investor Conferences
-
New Vertex Research Highlights Rising Revenue Risk from IT, Tax, and Finance Misalignment
-
Blossom Gold Files Notice of Intent with the BLM to Initiate Exploration Drilling on the Kamma Claims West of the Rosebud Project
-
Cullinan Therapeutics Receives FDA Orphan Drug Designation for CLN-049, a Novel FLT3xCD3 T Cell Engager, in Relapsed/Refractory Acute Myeloid Leukemia
-
Consumers Accelerate Shift Toward DIY Vehicle Maintenance Amid Economic Pressures
-
OTC Markets Group Welcomes Cambria Gold Mines Inc. to OTCQX
-
Herantis Pharma partners with Indivi to enable detection of early treatment effects in upcoming HER-096 Phase 2 trial in Parkinson’s disease
